Renaissance BioScience Appoints Dr. James Tansey to Board of Directors

Renaissance BioScience Corp., a global leader in yeast bioengineering, announced the appointment of Dr. James Tansey to its Board of Directors. Dr. Tansey brings extensive experience as a serial entrepreneur, research academic, and business leader, with a focus on life sciences, technology commercialization, and corporate governance. He is a Professor at the University of British Columbia's Sauder School of Business and previously served on the faculty at Oxford University's Saïd Business School. Dr. Tansey is also a member of the founding team at Gemina Labs, serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund.

The appointment aligns with Renaissance's strategy to commercialize its innovative yeast bioengineering platforms, which include yeast-produced RNA and yeast-derived virus-like particles (VLPs) for applications in crop protection and future uses in animal and human health. Maurice Boucher, Renaissance Co-Founder and Executive Chairman, highlighted Dr. Tansey's alignment with the company's focus on environmental sustainability, stating, "James has consistently focused on 'Impact Investing' and environmental protection and sustainability throughout his exceptional career, which fits well with the positive environmental impact of Renaissance's technology platforms." Dr. Tansey's expertise is expected to support Renaissance as it continues developing and globally commercializing its biotechnology platforms.

Dr. Tansey expressed enthusiasm about joining the board, noting that Renaissance has "developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health." He looks forward to working with the board and management team to execute the company's growth strategy and create long-term value.

Dr. John Husnik, Renaissance Co-Founder, Director and CSO, emphasized that Dr. Tansey's experience in building companies, securing investment, and moving innovative technologies toward commercialization will complement the company's scientific expertise. Renaissance BioScience Corp., based in Vancouver, Canada, is a global-leading yeast bioengineering company developing market-ready, functional microorganisms to address environmental and industrial challenges in agriculture, food, nutrition, and animal and human health. For more information, visit www.renaissancebioscience.com.